Literature DB >> 22971717

Surgical results of video-assisted thoracic surgery and risk factors for prolonged hospitalization for secondary pneumothorax in elderly patients.

Katsunari Matsuoka1, Ayumi Kuroda, Angyoung Kang, Naoko Imanishi, Shinjiro Nagai, Mitsuhiro Ueda, Yoshihiro Miyamoto.   

Abstract

BACKGROUND: The treatment of secondary pneumothorax in elderly patients is difficult because of underlying diffuse lung injury and complex medical comorbidities. Such patients still have high morbidity rates, resulting in longer periods of hospitalization.
METHODS: To examine the results of video-assisted thoracic surgery for elderly patients (aged 70 years or over) with secondary pneumothorax and investigate the risk factors for hospital stay longer than 7 days, we retrospectively analyzed the results obtained in such patients at our institution.
RESULTS: From among 73 patients who entered this study, 7 patients (9.6%) had postoperative complications. Video-assisted thoracic surgery could treat pneumothorax in 71 patients, except for the 2 who died in hospital. The median postoperative drainage and hospital stay periods were 2 days (1-40 days) and 5 days (2-51 days). Patients with interstitial pneumonitis, pulmonary infection and low total protein or sodium levels were the risk factors for hospital stay longer than 7 days.
CONCLUSIONS: VATS is a safe and effective procedure for secondary pneumothorax in elderly patients. Patients with interstitial pneumonitis, pulmonary infection, and hyponutrition state were the risk factors for postoperative hospital stay prolongation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971717     DOI: 10.5761/atcs.oa.12.01909

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  8 in total

1.  Should we wait for the bubble to explode?

Authors:  Si Young Choi; Hyun Woo Jeon; Chan Beom Park
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  The outcome and risk factors for recurrence and extended hospitalization of secondary spontaneous pneumothorax.

Authors:  Yoshitaro Saito; Yohei Suzuki; Ryo Demura; Hideki Kawai
Journal:  Surg Today       Date:  2017-09-13       Impact factor: 2.549

3.  The frequency and treatment of pneumothorax associated with pulmonary nontuberculous mycobacterial infection.

Authors:  Masaki Ikeda; Koji Takahashi; Teruya Komatsu; Toru Tanaka; Tatsuo Kato; Takuji Fujinaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-12-03

4.  Risk factors related to the recurrence of pneumothorax in patients with emphysema.

Authors:  Beomsu Shin; Sae Byol Kim; Chang Wan Kim; Il Hwan Park; Won-Yeon Lee; Chun Sung Byun
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

5.  Fate of spontaneous pneumothorax from middle to old age: how to overcome an irritating recurrence?

Authors:  Seung Hyuk Nam; Kun Woo Kim; Sung-Whan Kim; Si-Wook Kim; Jong-Myeon Hong; Dohun Kim
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Medical Thoracoscopy-Assisted Argon Plasma Coagulation Combined with Electrosurgical Unit for the Treatment of Refractory Pneumothorax in Elderly Patients.

Authors:  Hai-Yan Guo; Xiao-Qing Pan; Ming Hu; Yong-Feng Liang; Xin-Cai Qiu; Zhen-Hua Chen
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-07-04       Impact factor: 1.520

7.  Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases.

Authors:  Gian Luca Casoni; Sara Tomassetti; Alberto Cavazza; Thomas V Colby; Alessandra Dubini; Jay H Ryu; Elisa Carretta; Paola Tantalocco; Sara Piciucchi; Claudia Ravaglia; Christian Gurioli; Micaela Romagnoli; Carlo Gurioli; Marco Chilosi; Venerino Poletti
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Non-intubated anesthesia in patients undergoing video-assisted thoracoscopic surgery: A systematic review and meta-analysis.

Authors:  Mei-Gang Yu; Ren Jing; Yi-Jie Mo; Fei Lin; Xue-Ke Du; Wan-Yun Ge; Hui-Jun Dai; Zhao-Kun Hu; Sui-Sui Zhang; Ling-Hui Pan
Journal:  PLoS One       Date:  2019-11-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.